“…Small EVs are the most well described in the setting of cancer 27 and are also the predominant size found in intraocular biofluids. 31 – 35 For cancer, tumor-derived sEVs have been shown to promote tumor formation, progression, treatment resistance, and metastases 24 , 36 , 37 allowing for the discovery of diagnostic and prognostic biomarkers for multiple cancer types, including breast, 38 lung, 39 , 40 gastric, 36 and melanoma, 41 among others. 24 In the eyes, sEVs have been investigated in diseases including age-related macular degeneration, retinal vascular disease, glaucoma, uveitis, and thyroid eye disease, primarily through analysis of tissue, cell lines, and serum, whereas AH studies are limited.…”